TrialJournal of the American Heart Association2021

Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial.

Jawad H Butt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.